Koninklijke Philips N.V. - Form 6-K
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

October 11, 2017

Koninklijke Philips N.V.
———————————————————————————————————
(Translation of registrant’s name into English)
 
The Netherlands
———————————————————————————————————
(Jurisdiction of incorporation or organization)
 
Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands
———————————————————————————————————
(Address of principal executive office)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:  [x] Form 20-F    [ ] Form 40-F
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  [ ]
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  [ ]
 
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:  [ ] Yes    [x] No
 
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):    n/a 
 

Philips reaches agreement with the U.S. government on a consent decree focusing
on the company’s defibrillator manufacturing in the U.S.

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
    Koninklijke Philips N.V.
     
Date: 10/11/2017 By: /s/ M.J. van Ginneken

  Name:  M.J. van Ginneken
  Title: Chief Legal Officer
     

EXHIBIT INDEX

Exhibit No.   Description

 
2.ex-99   press release